Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hofman

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategiesM I Ilie, C Bence, V Hofman, et al.
British Journal of Cancer|January 10, 2008
Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cellsP Lagadec, E Griessinger, M P Nawrot, et al.
Oncogene|September 15, 2015
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2G M De Donatis, E Le Pape, A Pierron, et al.
Oncogene|May 27, 2016
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2G M De Donatis, E Le Pape, A Pierron, et al.
Epilepsy Research|August 25, 2005
Language activation distributions revealed by fMRI in post-operative epilepsy patients: differences between left- and right-sided resectionsW H Backes, K Deblaere, K Vonck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcomaO Feugeas, N Guriec, A Babin-Boilletot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2015
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)E Long, M Ilie, S Lassalle, et al.
ESMO Open|February 24, 2022
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancerE Heitzer, D van den Broek, M G Denis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patientsM Ilie, E Long, V Hofman, et al.
Seizure|June 11, 2018
MEG-guided analysis of 7T-MRI in patients with epilepsyA J Colon, M J P van Osch, M Buijs, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategiesM I Ilie, C Bence, V Hofman, et al.
British Journal of Cancer|January 10, 2008
Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cellsP Lagadec, E Griessinger, M P Nawrot, et al.
Oncogene|September 15, 2015
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2G M De Donatis, E Le Pape, A Pierron, et al.
Oncogene|May 27, 2016
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2G M De Donatis, E Le Pape, A Pierron, et al.
Epilepsy Research|August 25, 2005
Language activation distributions revealed by fMRI in post-operative epilepsy patients: differences between left- and right-sided resectionsW H Backes, K Deblaere, K Vonck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcomaO Feugeas, N Guriec, A Babin-Boilletot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2015
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)E Long, M Ilie, S Lassalle, et al.
ESMO Open|February 24, 2022
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancerE Heitzer, D van den Broek, M G Denis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patientsM Ilie, E Long, V Hofman, et al.
Seizure|June 11, 2018
MEG-guided analysis of 7T-MRI in patients with epilepsyA J Colon, M J P van Osch, M Buijs, et al.
Pageof 24